US Patent Issued to Ellodi Pharmaceuticals on July 28 for "Methods of treating eosinophilic esophagitis and reducing candidiasis" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,128, issued on July 28, was assigned to Ellodi Pharmaceuticals LP (Blue Bell, Pa.).

"Methods of treating eosinophilic esophagitis and reducing candidiasis" was invented by James Nezamis (Blue Bell, Pa.), Gina Eagle (Blue Bell, Pa.), Mark Marino (Blue Bell, Pa.) and Peter Richardson (Blue Bell, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for treating eosinophilic oesophagitis with corticosteroids. The methods for treating eosinophilic oesophagitis disclosed herein result in reduced corticosteroid side effects, e.g. candidiasis. Dosages, formulations, and methods for administration of corticosteroids are provided."...